KEYTRUDA

• drugpembrolizumab515 co-mentions · 131 sources
• tagApproval512 co-mentions · 128 sources
• drugKEYTRUDA QLEX269 co-mentions · 131 sources
• drugCancer Program256 co-mentions · 128 sources
• drug(berahyaluronidase alfa + pembrolizumab)10 co-mentions · 5 sources
• tagGlioblastoma2 co-mentions · 1 sources
• tagNeurology1 co-mentions · 1 sources
• drugaxelopran1 co-mentions · 1 sources

Trials studying KEYTRUDA

• phase2Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumorscompletedn=161
• phase2Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)recruitingn=298
• phase3A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancerrecruitingn=500
• phase1A Study of Sigvotatug Vedotin in Advanced Solid Tumorsrecruitingn=1,006
• phase2Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinomaactive not recruitingn=31
• phase2A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumorsterminatedn=13
• phase2Pan Tumor Rollover Studyrecruitingn=1,500
• phase2Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancerwithdrawn